Reengineering Estrogen Receptor Hormone Specificity Through Coordinated Changes at Key Contact Sites Between Estrogen Receptor and Estradiol
Thomas, James Adrian
This item is only available for download by members of the University of Illinois community. Students, faculty, and staff at the U of I may log in with your NetID and password to view the item. If you are trying to access an Illinois-restricted dissertation or thesis, you can request a copy through your library's Inter-Library Loan office or purchase a copy directly from ProQuest.
Permalink
https://hdl.handle.net/2142/86771
Description
Title
Reengineering Estrogen Receptor Hormone Specificity Through Coordinated Changes at Key Contact Sites Between Estrogen Receptor and Estradiol
Author(s)
Thomas, James Adrian
Issue Date
2001
Doctoral Committee Chair(s)
Katzenellenbogen, Benita S.
Department of Study
Microbiology
Discipline
Microbiology
Degree Granting Institution
University of Illinois at Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
Biology, Molecular
Language
eng
Abstract
The specificity of hormone action arises principally from the specific interaction that a hormonal ligand has with its cognate receptor. This interaction is defined by steric and electronic complementarity at certain sites at which portions of the ligand contact specific residues in its receptor. In the nuclear hormone receptors, mutational mapping studies, and more recently, X-ray structures, provide information on these key, specificity-defining contact sites. Based on this information, we have made a series of coordinated changes in the A-ring of estrogens (E) and in the A-ring binding sub-pocket of the estrogen receptor alpha (ER). This is the site at which the 3-phenolic hydroxyl of estrogens is hydrogen bonded to the side chains of Glu353 and Arg394. These changes are designed to create a favorable interaction when both E and ER are changed, but to disfavor interaction when only E is changed or only ER is changed. We have evaluated several altered ligand (E') and receptor (ER') pairs in quantitative ligand binding and reporter gene assays. The most successful coordinated changes have involved the change of Glu353 to a serine or alanine residue coupled with a change of the 3-OH of estradiol to a carboxymethyl or an ethoxy group, respectively. In these cases, the rematched interaction E'-ER' is more favorable than the mismatched ones. These new ligand receptor pairs represent the creation of new hormone specificities. To examine the utility of these ligand receptor rematches for the regulation of transgenes, we have made chimeric receptors that combine the DNA binding domain of Gal4 with the ligand binding domain of wild type, E353S or E353A mutant ER and the activation domain of VP16. These chimeric proteins were tested in mammalian cell transfection assays, and although these chimeric receptors required higher levels of ligand than the full length receptor, the specificity shifts mirrored those we had seen previously. These chimeric receptor-ligand pairs do show promise for use in artificial regulation of gene activity, but some additional work would be required to optimize the chimeric receptor-altered ligand pairs for this function.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.